Clinical Trial Update: Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC [Phase 1]

View source ↗

Summary

Open-label Phase 1 dose-escalation study to assess safety and preliminary efficacy of TN-401 in adults with PKP2 mutation-associated Arrhythmogenic Right Ventri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmogenic Right Ventricular Cardiomyopathy

Drugs mentioned

• TN-401

Snippet

Sponsor: Tenaya Therapeutics | Conditions: Arrhythmogenic Right Ventricular Cardiomyopathy | Phase 1 | Status: RECRUITING